- Home
- IDCC vs RVMD Comparison
IDCC vs RVMD Comparison
Compare IDCC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDCC
- RVMD
- Stock Information
- Founded
- IDCC 1972
- RVMD 2014
- Country
- IDCC United States
- RVMD United States
- Employees
- IDCC N/A
- RVMD N/A
- Industry
- IDCC Multi-Sector Companies
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IDCC Miscellaneous
- RVMD Health Care
- Exchange
- IDCC Nasdaq
- RVMD Nasdaq
- Market Cap
- IDCC 6.9B
- RVMD 7.5B
- IPO Year
- IDCC N/A
- RVMD 2020
- Fundamental
- Price
- IDCC $322.87
- RVMD $46.55
- Analyst Decision
- IDCC Strong Buy
- RVMD Strong Buy
- Analyst Count
- IDCC 1
- RVMD 16
- Target Price
- IDCC $350.00
- RVMD $73.56
- AVG Volume (30 Days)
- IDCC 277.4K
- RVMD 2.0M
- Earning Date
- IDCC 10-30-2025
- RVMD 11-05-2025
- Dividend Yield
- IDCC 0.74%
- RVMD N/A
- EPS Growth
- IDCC 43.26
- RVMD N/A
- EPS
- IDCC 14.28
- RVMD N/A
- Revenue
- IDCC $892,584,000.00
- RVMD N/A
- Revenue This Year
- IDCC N/A
- RVMD N/A
- Revenue Next Year
- IDCC N/A
- RVMD $387.56
- P/E Ratio
- IDCC $22.59
- RVMD N/A
- Revenue Growth
- IDCC 21.83
- RVMD N/A
- 52 Week Low
- IDCC $131.29
- RVMD $29.17
- 52 Week High
- IDCC $327.49
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- IDCC 78.17
- RVMD 78.30
- Support Level
- IDCC $265.14
- RVMD $39.73
- Resistance Level
- IDCC $270.89
- RVMD $41.60
- Average True Range (ATR)
- IDCC 8.80
- RVMD 1.84
- MACD
- IDCC 3.94
- RVMD 0.88
- Stochastic Oscillator
- IDCC 92.69
- RVMD 95.71
About IDCC InterDigital Inc.
InterDigital Inc is a research and development company focused on wireless, video, Artificial Intelligence, and related technologies. It designs and develops technologies that enable connected, immersive experiences in a broad range of communications and entertainment products and services. The majority of revenue is generated from fixed-fee patent license agreements, with a smaller portion coming from variable royalty agreements. Geographically it operates in the United States, China, South Korea, Japan, Taiwan, and Europe, out of which the majority is from China.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.